These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37774224)

  • 1. Total Bilirubin Levels in Nonalcoholic Fatty Liver Disease and All- cause and Cause-specific Mortality in US Adults.
    Moss K; Dennis BB; Naji L; Ahmed A; Kim D
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):323-331. PubMed ID: 37774224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-linear associations of circulating total bilirubin concentration with the risk of nonalcoholic fatty liver disease and all-cause mortality.
    Han H; Yu Q; Qin N; Song B; Meng Y; Feng Z; Li Z; Chen L
    Ann Hepatol; 2024; 29(2):101177. PubMed ID: 37924867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
    Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
    Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease.
    Kim D; Murag S; Cholankeril G; Cheung A; Harrison SA; Younossi ZM; Ahmed A
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1240-1247.e5. PubMed ID: 32683103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality.
    Kim D; Manikat R; Shaikh A; Cholankeril G; Ahmed A
    Eur J Clin Invest; 2024 Jan; 54(1):e14087. PubMed ID: 37638383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
    Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
    Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease.
    Zhao E; Cheng Y; Yu C; Li H; Fan X
    Ann Med; 2023 Dec; 55(1):2197652. PubMed ID: 37052341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality.
    Yoo ER; Kim D; Vazquez-Montesino LM; Escober JA; Li AA; Tighe SP; Fernandes CT; Cholankeril G; Ahmed A
    Liver Int; 2020 Apr; 40(4):815-824. PubMed ID: 31910319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.
    Kwak MS; Kim D; Chung GE; Kang SJ; Park MJ; Kim YJ; Yoon JH; Lee HS
    Clin Mol Hepatol; 2012 Dec; 18(4):383-90. PubMed ID: 23323254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality.
    Konyn P; Alshuwaykh O; Dennis BB; Cholankeril G; Ahmed A; Kim D
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):940-948.e2. PubMed ID: 35643414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum uric acid with all-cause and cardiovascular mortality among adults with nonalcoholic fatty liver disease.
    Yang S; Ye Z; Liu M; Zhang Y; Wu Q; Zhou C; Zhang Z; He P; Zhang Y; Li H; Liu C; Qin X
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):49-58. PubMed ID: 35968564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality.
    Kim D; Vazquez-Montesino LM; Escober JA; Fernandes CT; Cholankeril G; Loomba R; Harrison SA; Younossi ZM; Ahmed A
    Am J Gastroenterol; 2020 Sep; 115(9):1496-1504. PubMed ID: 32496342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers.
    Chang Y; Ryu S; Zhang Y; Son HJ; Kim JY; Cho J; Guallar E
    PLoS One; 2012; 7(5):e37241. PubMed ID: 22615952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
    Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
    BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium intake in relation to all-cause and cardiovascular mortality in individuals with nonalcoholic fatty liver disease: A nationwide study in nutrition.
    Dong X; Deng Y; Chen G
    PLoS One; 2024; 19(5):e0303140. PubMed ID: 38768120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.
    Kim D; Konyn P; Sandhu KK; Dennis BB; Cheung AC; Ahmed A
    J Hepatol; 2021 Dec; 75(6):1284-1291. PubMed ID: 34380057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.
    Kim D; Yoo ER; Li AA; Cholankeril G; Tighe SP; Kim W; Harrison SA; Ahmed A
    Liver Int; 2019 Jul; 39(7):1335-1342. PubMed ID: 30924602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
    Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.